9.83% -0.1199

Fibrogen Inc (FGEN)

Fibrogen Inc (FGEN) 最新ニュース

Fibrogen Inc (FGEN)

Fibrogen Inc (FGEN) 最新ニュース

FibroGen | The Pharmaletter - The Pharma Letter

FibroGen | The Pharmaletter - The Pharma Letter

FibroGen | The Pharmaletter - The Pharma Letter

Investing in FibroGen Inc (FGEN) might be a great opportunity, but the stock is a bit overvalued – US Post News - US Post News

Analysts review FibroGen Inc's rating – Knox Daily - Knox Daily

Behind FibroGen Inc’s 52-Week Range: Uncovering Opportunities for Investors - The InvestChronicle

Closing Bell Recap: FibroGen Inc (FGEN) Ends at 1.10, Reflecting a 6.80 Upturn – DWinneX - The Dwinnex

Chief Medical Officer Adib Deyaa acquired 22123 shares of FibroGen Inc [FGEN] – Knox Daily - Knox Daily

Prepare Yourself for Liftoff: FibroGen Inc (FGEN) – Sete News - SETE News

FibroGen, Inc.'s (NASDAQ:FGEN) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures - Simply Wall St

Is FibroGen (NASDAQ:FGEN) A Risky Investment? - Yahoo Lifestyle UK

Fibrogen (FGEN)/Astellas Get EU Nod for Roxadustat for Anemia - Yahoo Movies UK

FibroGen to Host Part II of Virtual KOL Investor Event - GlobeNewswire

FibroGen to Host Part II of Virtual KOL Investor Event - GlobeNewswire

Can you now get a good deal on FibroGen Inc's shares? – US Post News - US Post News

Favourable Signals For FibroGen: Numerous Insiders Acquired Stock - Yahoo Finance

FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic ... - GlobeNewswire

Fibrogen (FGEN)/Astellas Get EU Nod for Roxadustat for Anemia - Yahoo Singapore News

A Guide To The Risks Of Investing In FibroGen Inc (FGEN) – Knox Daily - Knox Daily

AstraZeneca/Fibrogen's Roxadustat FDA Review Further Delayed Following Unanticipated Advisory Committee Request - Yahoo Finance

Deyaa Adib Buys 22123 Shares of FibroGen, Inc. (NASDAQ:FGEN) Stock - Defense World

Fibrogen executive buys $25,883 in company stock By Investing.com - Investing.com Australia

Fibrogen executive buys $25,883 in company stock By Investing.com - Investing.com

FibroGen, Inc. (NASDAQ:FGEN) Insider Purchases $25,883.91 in Stock - MarketBeat

Fibrogen executive buys $25,883 in company stock By Investing.com - Investing.com UK

FibroGen Inc [FGEN] stock for 95,470 USD was bought by Wettig Thane - Knox Daily

Are Smart Investors Making the Right Decision? FibroGen Inc (FGEN) – Sete News - SETE News

Fibrogen executive buys $25883 in company stock - Investing.com India

153764 Shares in FibroGen, Inc. (NASDAQ:FGEN) Bought by Lighthouse Investment Partners LLC - Defense World

Pennant Investors LP Buys New Position in FibroGen, Inc. (NASDAQ:FGEN) - MarketBeat

FibroGen Inc (FGEN) presents a great opportunity, but the stock is slightly overvalued – US Post News - US Post News

FibroGen Inc (FGEN) presents a great opportunity, but the stock is slightly overvalued – US Post News - US Post News

Investing in FibroGen Inc (FGEN): What You Must Know – Knox Daily - Knox Daily

Roxadustat Approval Might Hinge On Additional Safety Analyses After FibroGen Admits Manipulating Data - Pink Sheet

CEO Wettig Thane acquire 50000 shares of FibroGen Inc [FGEN] – Knox Daily - Knox Daily

FibroGen: Two New In-Licensed Oncology Drugs To Carry It Forward (NASDAQ:FGEN) - Seeking Alpha

Armistice Capital LLC Buys 1,872,000 Shares of FibroGen, Inc. (NASDAQ:FGEN) - MarketBeat

FibroGen (FGEN) Soars: Stock Adds 9.6% in Session - Yahoo New Zealand News

Armistice Capital LLC Buys 1,872,000 Shares of FibroGen, Inc. (NASDAQ:FGEN) - MarketBeat

What's Going On With FibroGen Stock Tuesday? - MSN

FibroGen (FGEN) Soars: Stock Adds 9.6% in Session - Yahoo New Zealand News

Top investors say FibroGen Inc (FGEN) ticks everything they need – Sete News - SETE News

What's Going On With FibroGen Stock Tuesday? - FibroGen (NASDAQ:FGEN) - Benzinga

Keeping an Eye on FibroGen Inc (FGEN) After Insider Trading Activity – Knox Daily - Knox Daily

FibroGen to test new cancer therapies with Regeneron By Investing.com - Investing.com Australia

FibroGen to test new cancer therapies with Regeneron - Investing.com India

FibroGen, Inc. (NASDAQ:FGEN) Short Interest Update - Defense World

FibroGen (NASDAQ:FGEN) Receives Market Perform Rating from William Blair - Defense World

FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting ... - GlobeNewswire

FibroGen (NASDAQ:FGEN) Receives Market Perform Rating from William Blair - Defense World

FGENに似た銘柄